Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-562-2 | CAS number: 2814-77-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 2013
- Reliability:
- 1 (reliable without restriction)
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- 1-(4-methyl-2-nitrophenylazo)-2-naphthol
- EC Number:
- 219-372-2
- EC Name:
- 1-(4-methyl-2-nitrophenylazo)-2-naphthol
- Cas Number:
- 2425-85-6
- Molecular formula:
- C17H13N3O3
- IUPAC Name:
- 1-[(4-methyl-2-nitrophenyl)diazenyl]-2-naphthol
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Purity: 98.9%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: RccHan: WIST(SPF)
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Frequency of treatment:
- The purpose of this study was to generate preliminary information concerning the possible effects of repeated exposure of C.I. PIGMENT RED 3 over a limited period of time on male and female reproductive performance such as gonadal function, mating behavior, conception, development of the conceptus and parturition.
Four groups of 12 males and 12 females were treated by gavage with C.I. PIGMENT RED 3 once daily. Males were treated over a 14-day pre-pairing period and during the pairing period up to one day before necropsy. Females were treated throughout the pre-pairing, pairing, gestation and lactation period up to the day 3 post partum.
The following dose levels were used:
Group 1: 0 mg/kg body weight/day (control group)
Group 2 100 mg/kg body weight/day
Group 3: 300 mg/kg body weight/day
Group 4 1000 mg/kg body weight/day
A dose volume of 5 mL/kg body weight with a daily adjustment to the actual body weight was used. Control animals were dosed with the vehicle alone (polyethylene glycol 300).
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
1000 mg/kgbw/d
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
100 mg/kgbw/d
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
300 mg/kgbw/d
Basis:
- No. of animals per sex per dose:
- 12
- Control animals:
- yes, concurrent vehicle
Results and discussion
Results: P0 (first parental generation)
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- > 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable
- Remarks:
- no NOAEL identified Generation not specified (migrated information)
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
The following results were obtained:
1.1 Parent Animals
Mortality and General Tolerability
Five males died during the course of the study. The cause of death was in four animals related to aspiration of the test item. For one animal that cause of death could not be established because no necropsy was performed, but likely was similar in nature.
All other animals survived until the scheduled necropsy.
Food Consumption
The mean daily food consumption of all test item-treated males compared well with this of the control males during the pre-pairing period.
There were no statistically significant differences between the mean food consumption values of test item-treated females compared with the controls during pre-pairing, gestation and lactation.
Body Weights
There were no test item-related effects upon body weights of either males or females.
Reproduction and Breeding Data
No effects on mating performance, fertility, corpora lutea count or duration of gestation were observed at any dose level.
Organ Weights
No test item-related effects on organ weights of males were noted at any dose level.
Macroscopic Findings and Histopathological Examinations
No test item-related macroscopic findings were noted at any dose level.
There were no gross lesions recorded at necropsy that could be attributed to treatment. However, there were findings related to aspiration of the test item into the lungs. All other lesions recorded were within the expected range of gross lesions that may be recorded in animals at this age.
In the reproductive organs, all findings recorded were within the range of normal background lesions which may be recorded in animals of this strain and age. There were only single cases with isolated tubules that showed minor changes. They consisted of single sperm resorptions in stage VIII, IX or X tubules, some cases of single sperm retentions in a Stage IX tubule, and in one case, a single tubule was completely degenerated.
No histological evidence of a direct toxicological property in the reproductive organs and tissues examined was detected. Therefore the No Observed Adverse Effect Level (NOAEL) for reproductive toxicity was considered to be at 1000 mg/kg/day.
1.2 Litter Data - F1 Pups
Findings at First Litter Check and during Lactation
No test item-related findings were noted in pups at any dose level.
The sex ratio of the test item-treated pups did not indicate any effects of toxicological relevance.
Pup Weights to Day 4 Post Partum
No test item-related effects on pup body weights were noted at any dose level.
Macroscopic Findings
No test item-related findings were found in pups at any dose level.
The test item caused no indication of toxicity in the testes. The stages were complete in all animals. There was no indicator for induced maturation arrest, increased resorption, necrosis or any other injury. Furthermore, there was no lesion in interstitial cells.
There were no lesions recorded in the ovaries.
Applicant's summary and conclusion
- Conclusions:
- Because fecal discoloration (i.e. a secondary passive finding) was noted in treated rats at all dose levels, a NOEL (No Observed Effect Level) could not be established.
Based on the data generated from this reproduction / developmental toxicity screening test, the no observed adverse effect level (NOAEL) is established at 1000 mg/kg body weight for general toxicity and reproduction in parental animals and for developmental toxicity in the pups. - Executive summary:
The purpose of this study was to generate preliminary information concerning the possible effects of repeated exposure of C.I. PIGMENT RED 3 over a limited period of time on male and female reproductive performance such as gonadal function, mating behavior, conception, development of the conceptus and parturition.
Four groups of 12 males and 12 females were treated by gavage with C.I. PIGMENT RED 3 once daily. Males were treated over a 14-day pre-pairing period and during the pairing period up to one day before necropsy. Females were treated throughout the pre-pairing, pairing, gestation and lactation period up to the day 3 post partum.
The following dose levels were used:
Group 1: 0 mg/kg body weight/day (control group)
Group 2 100 mg/kg body weight/day
Group 3: 300 mg/kg body weight/day
Group 4 1000 mg/kg body weight/day
A dose volume of 5 mL/kg body weight with a daily adjustment to the actual body weight was used. Control animals were dosed with the vehicle alone (polyethylene glycol 300).
The following results were obtained:
1.1 Parent Animals
Mortality and General Tolerability
Five males died during the course of the study. The cause of death was in four animals related to aspiration of the test item. For one animal that cause of death could not be established because no necropsy was performed, but likely was similar in nature.
All other animals survived until the scheduled necropsy.
Clinical Signs or Observations
No test item related clinical signs beside reddish discolored feces were noted.
Food Consumption
The mean daily food consumption of all test item-treated males compared well with that of the control males during the pre-pairing period.
There were no statistically significant differences between the mean food consumption values of test item-treated females compared with the controls during pre-pairing, gestation and lactation.
Body Weights
There were no test item-related effects upon body weights of either males or females.
Reproduction and Breeding Data
No effects on mating performance, fertility, corpora lutea count or duration of gestation were observed at any dose level.
Organ Weights
No test item-related effects on organ weights of males were noted at any dose level.
Macroscopic Findings and Histopathological Examinations
No test item-related macroscopic findings were noted at any dose level.
There were no gross lesions recorded at necropsy that could be attributed to treatment. However, there were findings related to aspiration of the test item into the lungs. All other lesions recorded were within the expected range of gross lesions that may be recorded in animals at this age.
In the reproductive organs, all findings recorded were within the range of normal background lesions which may be recorded in animals of this strain and age. There were only single cases with isolated tubules that showed minor changes. They consisted of single sperm resorptions in stage VIII, IX or X tubules, some cases of single sperm retentions in a stage IX tubule, and in one case, a single tubule was completely degenerated.
The test item caused no indication of toxicity in the testes. The stages were complete in all animals. There was no indicator for induced maturation arrest, increased resorption, necrosis or any other injury. Furthermore, there was no lesion in interstitial cells.
There were no lesions recorded in the ovaries.
No macroscopic or histological evidence of a direct toxicological property in the organs and tissues examined was detected. Therefore the No Observed Adverse Effect Level (NOAEL) for general toxicity and for reproductive toxicity was considered to be 1000 mg/kg/day.
1.2 Litter Data - F1 Pups
Findings at First Litter Check and during Lactation
No test item-related findings were noted in pups at any dose level.
The sex ratio of the test item-treated pups did not indicate any effects of toxicological relevance.
Pup Weights to Day 4 Post Partum
No test item-related effects on pup body weights were noted at any dose level.
Macroscopic Findings
No test item-related findings were noted in pups at any dose level.
1.3 Conclusion
Because fecal discoloration (i.e. a secondary passive finding) was noted in treated rats at all dose levels, a NOEL (No Observed Effect Level) could not be established.
Based on the data generated from this reproduction / developmental toxicity screening test, the no observed adverse effect level (NOAEL) is established at 1000 mg/kg body weight for general toxicity and reproduction in parental animals and for developmental toxicity in the pups.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.